Exercise improves efficacy of levodopa in patients with Parkinson's disease
Authors:
- 16 January 2007
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 22 (3) , 427-430
Abstract
The objective was to investigate the impact of exercise on absorption and efficacy of levodopa (LD) in patients with Parkinson‘s disease (PD). A soluble, immediate release LD formulation was given followed by exercise near the aerobic limit on one day to PD patients, who underwent the same procedure only at rest on the second day. LD plasma behavior did not significantly differ between both conditions, but the motor response was significantly better 120 and 150 min after LD intake on the day with exercise than on the day with rest. Moderate exercise increases clinical efficacy of LD. © 2007 Movement Disorder SocietyKeywords
This publication has 10 references indexed in Scilit:
- Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease PatientsClinical Neuropharmacology, 2006
- Human White Blood Cells Synthesize Morphine: CYP2D6 ModulationThe Journal of Immunology, 2005
- Endogenous Opioids in Dopaminergic Cell Body Regions Modulate Amphetamine-Induced Increases in Extracellular Dopamine Levels in the Terminal RegionsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscleNeuroscience Research, 2001
- The effect of exercise on pharmacokinetics and pharmacodynamics of levodopaMovement Disorders, 2000
- Levodopa in plasma correlates with body weight of parkinsonian patientsParkinsonism & Related Disorders, 2000
- Enhanced fatigue during motor performance in patients with Parkinson's diseaseNeurology, 1998
- Blood levodopa levels and Unified Parkinson's Disease Rating Scale functionNeurology, 1993
- The effect of exercise on levodopa absorptionNeurology, 1992
- Exercise and the Antiparkinsonian Response to LevodopaClinical Neuropharmacology, 1987